FrancophonIA/ELRC3.0 huggingface dataset:
English: Flushed, dry skin, feeling sleepy or tired, dry mouth, fruity (acetone) breath, urinating more often, feeling thirsty, losing your appetite, feeling or being sick (nausea or vomiting).
Slovenian: Opozorilni znaki previsokega krvnega sladkorja - običajno se razvijejo postopoma Pordela in suha koža, občutek zaspanosti ali utrujenosti, suha usta, zadah z vonjem po sadju (acetonu), pogostejše uriniranje, žeja, izguba apetita, siljenje na bruhanje ali bruhanje.
English: • Lower appetite, feeling or being sick (nausea or vomiting), diarrhoea, constipation, indigestion (dyspepsia), inflamed lining of the stomach (gastritis), stomach ache, heartburn or bloatingthese usually go away after a few days or weeks.
Slovenian: (dispepsija), vnetje sluznice želodca (gastritis), bolečina v trebuhu, zgaga ali napihnjenost; ti neželeni učinki običajno minejo v nekaj dneh ali tednih.
English: If you use GLP-1 treatment
Slovenian: AR GLP-1
English: Xultophy decreased the postprandial plasma glucose excursion (mean over 4 hours) significantly more than insulin degludec.
Slovenian: V primerjavi z insulinom degludek je zdravilo Xultophy pomembno bolj zmanjšalo povečanje koncentracije glukoze v plazmi po obroku (v povprečju za več kot 4 ure).
English: Xultophy is administered as ‘dose steps'.
Slovenian: Zdravilo Xultophy se odmerja v “odmernih korakih”.
English: The recommended starting dose of Xultophy is 10 dose steps (10 units insulin degludec and 0.36 mg liraglutide).
Slovenian: Priporočeni začetni odmerek zdravila Xultophy je 10 odmernih korakov (10 enot insulina degludek in
English: Gastrointestinal disorders
Slovenian: Koronarna revaskularizacija
English: Always remove the needle from your pen after each injection.
Slovenian: Po vsakem injiciranju odstranite iglo z injekcijskega peresnika.
English: Always use the dose counter and the dose pointer to see how many dose steps you have selected before injecting the medicine.
Slovenian: Pred injiciranjem zdravila s števcem in kazalnikom odmerka vedno preverite, koliko odmernih korakov ste izbrali.
English: Always keep the cap on the pre-filled pen when you are not using it in order to protect it from light.
Slovenian: Napolnjen injekcijski peresnik vedno shranjujte pokrit s pokrovčkom za zagotovitev zaščite pred svetlobo.
English: Other medicines and Xultophy
Slovenian: Uporaba zdravila Xultophy
English: • If you want to change your usual diet, check with your doctor, pharmacist or nurse first as a change in diet may alter your need for Xultophy.
Slovenian: • Če želite spremeniti svojo običajno prehrano, se najprej posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: One pre-filled pen contains 3 mL equivalent to 300 units insulin degludec and 10.8 mg liraglutide.
Slovenian: En napolnjen injekcijski peresnik vsebuje 300 enot insulina degludek in 10,8 mg liraglutida v 3 ml raztopine.
English: Please read these instructions carefully before using your Xultophy pre filled pen.
Slovenian: Pred uporabo napolnjenega injekcijskega peresnika Xultophy natančno preberite ta navodila.
English: Pack sizes of 1, 3, 5 and multipack containing 10 (2 packs of 5) pre-filled pens.
Slovenian: Velikosti pakiranja: 1, 3 in 5 napolnjenih injekcijskih peresnikov ter pakiranje po več enot, ki vsebuje
English: • Rash.
Slovenian: • srbenje
English: A reduction in HbA1c from baseline to month 36 was observed with liraglutide vs placebo, in addition to standard of care (-1.16% vs -0.77%; estimated treatment difference [ETD] -0.40% [-0.45; -0.34]).
Slovenian: poleg standardne oskrbe (-1,16 % napram -0,77 %; ocenjena razlika med zdravljenji -0,40 %
English: Digoxin median time to maximum concentration (tmax) was delayed from 1 h to 1.5 h. No dose adjustment of digoxin is required based on these results.
Slovenian: Pri sočasni uporabi liraglutida se je čas do največje koncentracije (tmax) obeh učinkovin podaljšal za 1,5 ure.
English: Pre-breakfast plasma glucose* Dose adjustment (twice weekly) mmol/L
Slovenian: Koncentracija glukoze v plazmi na tešče (mmol/l)
English: • oral contraceptives - birth control pills
Slovenian: • peroralne kontraceptive - tablete za preprečevanje zanositve, • ščitnične hormone - uporabljajo se za zdravljenje bolezni ščitnice,
English: • anabolic steroids - such as testosterone
Slovenian: • anabolne steroide (npr. testosteron), • zaviralce adrenergičnih receptorjev beta - zdravila za zdravljenje visokega krvnega tlaka.
English: Non-fatal Stroke
Slovenian: Možganska kap brez smrtnega izida
English: Stop using Xultophy and see a doctor straight away if they become serious.
Slovenian: Če postanejo resni, prenehajte uporabljati zdravilo Xultophy in nemudoma poiščite zdravniško pomoč.
English: Therefore, no dose adjustment of atorvastatin is required when given with liraglutide.
Slovenian: Pri sočasni uporabi atorvastatina in liraglutida odmerka atorvastatina ni treba prilagajati.
English: Clear, colourless, isotonic solution.
Slovenian: Bistra, brezbarvna, izotonična raztopina.
English: • If severe low blood sugar is not treated over time, it can cause brain damage.
Slovenian: • Nezdravljeno hudo znižanje koncentracije krvnega sladkorja lahko povzroči prehodno ali trajno okvaro možganov ali celo smrt.
English: • If the needle is removed earlier, you may see a stream of solution coming from the needle tip.
Slovenian: • Ko se števec odmerka vrne na 0, iglo pustite v koži in počasi štejte do • Če boste iglo izvlekli prej, lahko iz igle brizgne curek raztopine.
English: A number of substances affect glucose metabolism and may require dose adjustment of Xultophy.
Slovenian: Številne učinkovine vplivajo na presnovo glukoze in lahko tako vplivajo na odmerek zdravila
English: Package leaflet: Information for the patient Xultophy 100 units/mL + 3.6 mg/mL solution for injection insulin degludec + liraglutide
Slovenian: Navodilo za uporabo Xultophy 100 enot/ml + 3,6 mg/ml raztopina za injiciranje insulin degludek + liraglutid
English: Your pen is designed to be used with NovoTwist or NovoFine disposable needles up to a length of 8 mm and as thin as 32G.
Slovenian: NovoFine, dolžine do 8 mm in debeline 32G.
English: You should stop your GLP-1 treatment prior to starting on Xultophy.
Slovenian: Pred začetkom zdravljenja z zdravilom Xultophy morate zdravljenje z agonistom receptorjev GLP-1 prekiniti.
English: A new needle must always be attached before each use.
Slovenian: Za vsako injiciranje je treba vedno uporabiti novo injekcijsko iglo.
English: Do not use the pen scale, it only shows approximately how much solution is left in your pen.
Slovenian: Ta namreč prikazuje le koliko je približno še ostalo raztopine v injekcijskem peresniku.
English: Transfer to Xultophy from doses of basal insulin <20 and >50 units has not been studied.
Slovenian: Prehoda z zdravljenja z bazalnim insulinom v odmerkih, manjših od 20 enot in večjih od 50 enot, na zdravljenje z zdravilom Xultophy niso raziskali.
English: It is not known whether insulin degludec or liraglutide is excreted in human milk.
Slovenian: Kliničnih izkušenj z uporabo zdravila Xultophy med dojenjem ni. Ni znano, če se insulin degludek ali liraglutid izločata v materino mleko.
English: Batch
Slovenian: PAP
English: Your pen delivers doses in increments of 1 dose step.
Slovenian: Odmerek se lahko spreminja z natančnostjo 1 odmernega koraka.
English: Injection site reactions (including injection site haematoma, pain, haemmorrhage, erythema, nodules, swelling, discolouration, pruritus, warmth and injection site mass) have been reported in 2.6% of patients treated with Xultophy.
Slovenian: O reakcijah na mestu injiciranja (vključno s hematomom, bolečino, krvavitvijo, rdečino, vozliči,
English: Cholecystitis
Slovenian: Hipoglikemija
English: Estimated difference, insulin degludec dose
Slovenian: Odmerek na koncu preskušanja Insulin degludek
English: Xultophy is therefore not recommended in these patients.
Slovenian: Zdravila Xultophy ni mogoče priporočiti za zdravljenje bolnikov s končno odpovedjo ledvic
English: The maximum allowed dose was 50 dose steps for Xultophy and 50 units for insulin degludec.
Slovenian: Največji dovoljeni odmerek zdravila Xultophy je bil 50 odmernih korakov,
English: The dose selector clicks differently when turned forward, backward or past the number of dose steps left.
Slovenian: Izbirnik odmerka klika z drugačnim zvokom, ko ga obračate naprej,
English: • your blood sugar got so low that you passed out
Slovenian: Pogovorite se z zdravnikom, če: • se je krvni sladkor tako znižal, da ste se onesvestili,
English: Rate of confirmed hypoglycaemia* per patient year of exposure (percentage of patients) Estimated ratio
Slovenian: Delež hude hipoglikemije na bolnikov-let izpostavljenosti (odstotek bolnikov) je bil pri zdravilu
English: What measures are being taken to ensure the safe and effective use of Zirabev?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Zirabev?
English: The cancer responded to treatment in 45% of those given Zirabev (162 of 358 patients) and in 45% of those given Avastin (161 of 361).
Slovenian: Rak se je odzval na zdravljenje pri 45 % (162 od 358) bolnikov, ki so prejemali zdravilo Zirabev, in pri 45 % (161 od 361) bolnikov, ki so prejemali zdravilo Avastin.
English: The first infusion of Zirabev should last 90 minutes, but subsequent infusions may be given more quickly if the first infusion does not cause troublesome side effects.
Slovenian: Prva infuzija zdravila Zirabev naj traja 90 minut, poznejše infuzije pa so lahko krajše, če prva infuzija ni povzročila resnejših neželenih učinkov.
English: This means that Zirabev is highly similar to another biological medicine (the ‘reference medicine') that is already authorised in the EU.
Slovenian: To pomeni, da je zelo podobno drugemu biološkemu zdravilu („referenčnemu zdravilu“), ki je že odobreno v EU.
English: The dose, which is given every 2 or 3 weeks, depends on the patient's body weight, the type of cancer being treated and what other cancer medicines are being used.
Slovenian: Odmerek, ki se daje vsaka 2 ali 3 tedne, je odvisen od bolnikove telesne mase, vrste raka, ki se zdravi, in uporabe drugih zdravil za zdravljenje raka.
English: Treatment is continued until the patient no longer benefits from it.
Slovenian: Zdravljenje traja tako dolgo, dokler še koristi bolniku.
English: Zirabev received a marketing authorisation valid throughout the EU on 14 February 2019 Further information on Zirabev can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/zirabev.
Slovenian: Nadaljnje informacije o zdravilu Zirabev so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/zirabev.
English: Zirabev is a cancer medicine that is used to treat adults with the following cancers:
Slovenian: Zirabev je zdravilo za zdravljenje raka, ki se uporablja za zdravljenje odraslih z naslednjimi vrstami raka:
English: Side effects reported with Zirabev are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Zirabev, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Zirabev have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Zirabev upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: Why is Zirabev authorised in the EU?
Slovenian: Zakaj je zdravilo Zirabev odobreno v EU?
English: Other information about Zirabev
Slovenian: Druge informacije o zdravilu Zirabev
English: What benefits of Zirabev have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Zirabev izkazalo v študijah?
English: Zirabev must not be used in people who are hypersensitive (allergic) to bevacizumab or any of the other ingredients, to Chinese hamster ovary cell products or other recombinant antibodies.
Slovenian: Zdravila Zirabev ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) bevacizumab ali katero koli drugo sestavino zdravila, na pripravke iz celic jajčnika kitajskih hrčkov ali druga rekombinantna protitelesa.
English: For more information about using Zirabev, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Zirabev glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: The safety of Zirabev has been evaluated, and on the basis of all the studies carried out, the side effects of the medicine are considered to be comparable to those of the reference medicine Avastin.
Slovenian: Varnost zdravila Zirabev je bila ocenjena in na podlagi vseh izvedenih študij so bili neželeni učinki zdravila ocenjeni kot primerljivi z neželenimi učinki referenčnega zdravila Avastin.
English: Zirabev is used in combination with other cancer medicines, depending on the nature of any previous treatments or the presence of mutations (genetic changes) in the cancer that affect how well particular medicines work.
Slovenian: Zdravilo Zirabev se uporablja v kombinaciji z drugimi zdravili za zdravljenje raka, odvisno od narave predhodnih zdravljenj ali prisotnosti mutacij (genskih sprememb) pri raku, kar vpliva na občutljivost za določeno zdravilo.
English: Zirabev can only be obtained with a prescription and treatment should be supervised by a doctor who has experience in the use of cancer medicines.
Slovenian: Predpisovanje in izdaja zdravila Zirabev je le na recept, zdravljenje z njim pa mora biti pod nadzorom zdravnika, ki ima izkušnje z uporabo zdravil za zdravljenje raka.
English: An overview of Zirabev and why it is authorised in the EU
Slovenian: Pregled zdravila Zirabevin zakaj je odobreno v EU
English: What are the risks associated with Zirabev?
Slovenian: Kakšna tveganja so povezana z zdravilom Zirabev?
English: As for all medicines, data on the use of Zirabev are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Zirabev stalno spremljajo.
English: The active substance in Zirabev, bevacizumab, is a monoclonal antibody (a type of protein) that has been designed to attach to vascular endothelial growth factor (VEGF), a protein that circulates in the blood and encourages the growth of new blood vessels.
Slovenian: Učinkovina v zdravilu Zirabev, bevacizumab, je monoklonsko protitelo (vrsta beljakovine), zasnovano tako, da prepozna in se veže na endotelijski rastni faktor v žilah (VEGF), tj. beljakovino, ki kroži po krvi in omogoča rast krvnih žil.
English: The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Zirabev has a highly similar structure, purity and biological activity to Avastin and is distributed in the body in the same way.
Slovenian: Evropska agencija za zdravila je zaključila, da je bilo v skladu z zahtevami EU glede podobnih bioloških zdravil dokazano, da je zdravilo Zirabev po zgradbi, čistosti in biološkem delovanju primerljivo zdravilu Avastin in da se po telesu enako prenaša.
English: Because Zirabev is a biosimilar medicine, the studies on effectiveness and safety of bevacizumab carried out with Avastin do not all need to be repeated for Zirabev.
Slovenian: Zdravilo Zirabev je „podobno biološko zdravilo“, zato vseh študij o učinkovitosti in varnosti bevacizumaba, izvedenih z zdravilom Avastin, z zdravilom Zirabev ni treba ponavljati.
English: In addition, a study involving 719 patients with advanced non-small cell lung cancer showed that Zirabev was as effective as Avastin when given with the cancer medicines carboplatin and paclitaxel.
Slovenian: Poleg tega so v študiji, ki je vključevala 719 bolnikov z napredovalim nedrobnoceličnim rakom pljuč, pokazali, da je zdravilo Zirabev enako učinkovito kot zdravilo Avastin, če se daje v kombinaciji z drugima zdraviloma za zdravljenje raka, in sicer karboplatinom in paklitakselom.
English: Therefore, the Agency's view was that, as for Avastin, the benefits of Zirabev outweigh the identified risks and it can be authorised for use in the EU.
Slovenian: Zato je menila, da koristi zdravila Zirabev enako kot pri zdravilu Avastin odtehtajo znana tveganja in da se zdravilo lahko odobri v EU.
English: These data were considered sufficient to conclude that Zirabev will behave in the same way as Avastin in terms of effectiveness and safety in its authorised uses.
Slovenian: Vsi ti podatki so bili ocenjeni kot zadostni za zaključek, da se bo zdravilo Zirabev pri odobrenih uporabah z vidika učinkovitosti in varnosti vedlo enako kot zdravilo Avastin.
English: The reference medicine for Zirabev is Avastin.
Slovenian: Referenčno zdravilo za zdravilo Zirabev je zdravilo Avastin.
English: What is Zirabev and what is it used for?
Slovenian: Kaj je zdravilo Zirabevin za kaj se uporablja?
English: Zirabev contains the active substance bevacizumab and it is a ‘biosimilar medicine'.
Slovenian: Zdravilo Zirabev vsebuje učinkovino bevacizumab in je „podobno biološko zdravilo“.
English: Studies have also shown that giving Zirabev produces similar levels of the active substance in the body to giving Avastin.
Slovenian: Študije so pokazale tudi, da zdravilo Zirabev vzpostavi podobne ravni učinkovine v telesu kot zdravilo Avastin.
English: • cancer of the colon (large bowel) or the rectum (the last section of the bowel), when it has spread to other parts of the body;
Slovenian: • raka črevesja (debelega črevesa) ali danke (končni del črevesa), ki se je razširil na druge dele telesa;
English: Laboratory studies comparing Zirabev with Avastin have shown that the active substance in Zirabev is highly similar to that in Avastin in terms of structure, purity and biological activity.
Slovenian: Laboratorijske študije, v katerih so zdravilo Zirabev primerjali z zdravilom Avastin, so pokazale, da je učinkovina v zdravilu Zirabev po zgradbi, čistosti in biološkem delovanju zelo podobna učinkovini v zdravilu Avastin.
English: In addition, a study in non-small cell lung cancer has shown that Zirabev's effectiveness is equivalent to that of Avastin in this condition.
Slovenian: Poleg tega je študija nedrobnoceličnega raka pljuč pokazala, da je za to bolezen zdravilo Zirabev enako učinkovito kot zdravilo Avastin.
English: How is Zirabev used?
Slovenian: Kako se zdravilo Zirabev uporablja?
English: For the full list of side effects with Zirabev, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Zirabev, glejte navodilo za uporabo.
English: • cancer of the cervix (the neck of the womb) that has persisted or come back after treatment, or spread to other parts of the body.
Slovenian: • raka materničnega vratu, ki je prisoten tudi po zaključenem primarnem zdravljenju ali se je ponovil ali razširil na druge dele telesa.
English: • a lung cancer called non-small cell lung cancer when it is advanced or has spread or come back,
Slovenian: • pljučnega raka, imenovanega nedrobnocelični pljučni rak, kadar je napredoval ali se razširil ali se je vrnil, in ga ni mogoče zdraviti s kirurškim posegom; Zdravilo Zirabev se lahko uporablja le, če rak ne izvira iz določenih celic, imenovanih skvamozne celice;
English: Zirabev is given by infusion (drip) into a vein.
Slovenian: Zdravilo Zirabev se daje z infundiranjem (kapalno infuzijo) v veno.
English: How does Zirabev work?
Slovenian: Kako zdravilo Zirabev deluje?
English: Strength
Slovenian: Pot uporabe
English: 4 ampoules
Slovenian: 4 ampule
English: Solution for injection Intravenous use
Slovenian: Farmacevtska oblika Način uporabe zdravila Ovojnina
English: Ampoule (glass) 2 ml
Slovenian: 5 mg/ml Raztopina za injiciranje Intravenska uporaba Ampula (steklo) 2 ml
English: Invented name Strength Pharmaceutical form Route of administration Packaging Content (concentration) Package size EU/1/04/284/001 Pedea
Slovenian: EU/1/04/284/001 Pedea
English: • If you are a young adult.
Slovenian: • če ste mlajša odrasla oseba.
English: San Sebastian de los Reyes Spain
Slovenian: San Sebastian de los Reyes Španija
English: {Name and Address} {tel} {fax} {e-mail}
Slovenian: {Ime in naslov} {tel.} {faks} {e-mail}
English: 92931 Paris La Défense Cedex, France
Slovenian: 92931 Paris La Défense Cedex, Francija
English: The cause of these deaths is unknown.
Slovenian: Vzrok teh smrti je neznan.
English: There is a risk of an effect on the baby.
Slovenian: Obstaja nevarnost učinka na otroka.
English: Cyprus, Denmark, Finland, Greece, Iceland, Ireland, Malta, Norway, United Kingdom
Slovenian: Ciper, Danska, Finska, Grčija, Islandija, Irska, Malta, Norveška, Velika Britanija
English: Therefore, you should take special care in your dental hygiene.
Slovenian: Zato morate še posebej dobro skrbeti za zobno higieno.
English: Therefore, it should be used with caution in these patients.
Slovenian: Zato ga je pri teh bolnikih treba uporabljati previdno.
English: 1150 Vienna
Slovenian: 1150 Dunaj
English: The no-effect dose for these findings was 1.3 times the human dose.
Slovenian: Odmerek brez učinka za te ugotovitve je bil 1,3-krat večji od odmerka za ljudi.
English: The lowest effective dose should be maintained.
Slovenian: Najmanjši še učinkovit odmerek je treba vzdrževati.
English: Examples of these medicines include:
Slovenian: Taka zdravila so na primer:
English: A risk to the suckling child cannot be excluded.
Slovenian: Nevarnosti za dojenega otroka ni mogoče izključiti.
English: Frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), not known (cannot be estimated from the available data).
Slovenian: Pogostnosti so opredeljene kot: zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: This is most likely to occur within the first few weeks of treatment.
Slovenian: To se najpogosteje pojavi v prvih nekaj tednih zdravljenja.
English: Patients should be treated for a sufficient period of time, usually several months or longer.
Slovenian: Bolnike je treba zdraviti dovolj dolgo, navadno nekaj mesecev ali dlje.
English: (The “prevention of relapse of depression” indication was excluded since, based on current EU guidelines, the relapse indication is encompassed when approval for the indication of major depressive episodes is granted).
Slovenian: (Indikacija „preprečevanje ponovnega pojavljanja depresije“ je bila izključena, ker je na podlagi trenutnih smernic EU indikacija preprečevanja ponovnega pojavljanja vključena, kadar je odobreno soglasje za indikacijo hude depresivne epizode).
English: Uncommon: sensitivity to sunlight
Slovenian: Občasni: občutljivost za sončno svetlobo
English: This may increase the risk of caries.
Slovenian: To lahko poveča nevarnost kariesa.
English: These symptoms usually begin during the first 24 hours after the baby is born.
Slovenian: Ti simptomi se običajno pojavijo v prvih 24 urah po rojstvu otroka.
English: Absolute bioavailability is 40% to 45% due to presystemic metabolism.
Slovenian: Absolutna biološka uporabnost je zaradi predsistemske presnove 40 % do 45 %.
English: - “prevention of recurrence of major depressive episodes”, which was adequately supported by the data provided.
Slovenian: - „preprečevanje ponovnega pojavljanja hudih depresivnih epizod“, kar so predloženi podatki tudi ustrezno potrdili.
English: Do not drive or use any tools or machines until you know how Efexor affects you.
Slovenian: Ne vozite in ne uporabljajte orodja ali strojev, dokler ne ugotovite, kako zdravilo Efexor vpliva na vas.
English: If you notice any signs of the following, you may need urgent medical attention:
Slovenian: Če opazite katerega od spodnjih znakov, boste morda potrebovali takojšno zdravniško pomoč:
English: It may harm them, even if their symptoms are the same than yours.
Slovenian: Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim.
English: PHARMACEUTICAL FORM Tablet.
Slovenian: FARMACEVTSKA OBLIKA Tableta.
English: Recommended treatment
Slovenian: Priporočeno zdravljenje